Ozempic-maker's shares plunge after failed Alzheimer's trial
Sky News | 24.11.2025 21:15
Shares in Nov Nordisk, the Danish firm best known for its Wegovy and Ozempic weight loss drugs, have plunged after it called a halt to closely-watched trials on a treatment for Alzheimer's disease.
